Quantum BioPharma Ltd. (QNTM)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $9.26M
Last updated: Nov 17, 2026 at 4:31 PM ET
Quantum BioPharma Ltd. (QNTM) Statistics
Quantum BioPharma (QNTM) has a market cap of $9.26M and an enterprise value of $6.63M. Its share count is up 109.97% from a year earlier. It holds $2.63M more cash than debt, 28.43% of its market cap.
Total Valuation
Enterprise value is 28.43% below the market cap, as cash exceeds debt.
| Market Cap | $9.26M |
|---|---|
| Enterprise Value | $6.63M |
| Latest price (Nov 17, 2026) | $1.59 |
Key Dates
| Last Earnings Date | Nov 12, 2026 |
|---|---|
| Fiscal Year End | December |
Price Statistics
The stock is down 78.40% over 52 weeks and trades 43.82% below its 50-day average.
| Beta (1Y) | 0.53 |
|---|---|
| 52-Week Change | -78.40% |
| 1-Month Change | -34.02% |
| 3-Month Change | -54.83% |
| 6-Month Change | -77.29% |
| 5-Year Change | -97.36% |
| Total Return (1Y) | -78.40% |
| Total Return (3Y CAGR) | -72.44% |
| Total Return (5Y CAGR) | -56.01% |
| Return vs SPY (1Y) | -88.14% |
| Max Drawdown (1Y) | -87.38% |
| Max Drawdown (3Y) | -98.36% |
| Sharpe Ratio (1Y) | -1.08 |
| Correlation with SPY (1Y) | 0.05 |
| 50-Day Average | $2.83 |
| 200-Day Average | $3.65 |
| 52-Week Range | $1.33 to $12.42 |
| RSI (14 Days) | 27.3 |
| Average Volume (20 Days) | 104.28K |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 1.72x current liabilities, and total debt is 0.08x shareholder equity.
| Current Ratio | 1.72x |
|---|---|
| Quick Ratio | 1.72x |
| Debt / Equity | 0.08x |
| Interest Coverage | -52.98x |
Returns and Efficiency
Return on invested capital is -150.11% over the last 12 months.
| Return on Assets (ROA) | -143.60% |
|---|---|
| Return on Invested Capital (ROIC) | -150.11% |
| Inventory Turnover | 19.86x |
Scores
QNTM has a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 1 of 9 |
|---|---|
| Piotroski Strength | Weak |
Balance Sheet
| Cash and Equivalents | $3.56M |
|---|---|
| Total Debt | $923.83K |
| Net Cash | $2.63M |
| Net Cash Per Share | $0.33 |
Balance sheet as of Sep 30, 2026.
Stock Splits
The last split was a 1-for-65 reverse split on Aug 15, 2024.
| Last Split Date | Aug 15, 2024 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:65 |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About QNTM
What is QNTM's market cap?
Quantum BioPharma has a market cap of $9.26M. Its enterprise value, which adds debt and subtracts cash, is $6.63M.
How many shares of QNTM are outstanding?
Quantum BioPharma has 7.98M shares outstanding. The count is up 109.97% from a year earlier.
Does QNTM pay a dividend?
No. Quantum BioPharma does not pay a dividend.
How much debt does QNTM have?
Quantum BioPharma has $923.83K of total debt and $3.56M of cash and equivalents, a net cash position of $2.63M.
QNTM pages: Overview, Charting, Earnings, Statistics, Competitors